Publication Category

All Publication

CCI order restricts the scope of single economic entity concept in antitrust proceedings

CCI order restricts the scope of single economic entity concept in antitrust  proceedings - imposes penalty on two Aditya Birla Group companies and other for bid rigging in supply of

CCI dismisses allegations of anti-competitive conduct against NTPC Limited

Though the Order is not final and appealable, CCI in this prima facie order has recognized the sanctity of and has refused to intervene in the long term Power Purchase

Competition Commission of India delivers its First RPM decision

The Competition Commission of India (“CCI”) has imposed a penalty on Hyundai Motors India Limited (“HMIL”) for Resale Price Maintenance[1] (“RPM”). This has been the Country’s first

Transactions “solely as an investment” or in the “ordinary course of business”: Notification to the Competition Commission of India

The Competition Commission of India (CCI) recently penalized Cairnhill CIPEF Limited and Cairnhill CGPE Limited in relation to notification of acquisition of 11% equity shares of Mankind Pharma Limited. The

CCI closes allegation of abuse of dominance against WhatsApp

CCI vide its recent order dated June 01, 2017 has closed an allegation of abuse of dominant position against popular message service WhatsApp. The complaint against WhatsApp was filed

Interview of Mr. M.M. Sharma published in a Japanese magazine The Daily NNA

Interview of Mr. M.M. Sharma published in a Japanese magazine “The Daily NNA”, a part of the Kyodo News Group, based in Tokyo (http://news.nna.jp/ ) on select competition issues.

Link:

Why policymakers must stop awarding contracts to PSUs on nomination basis

Development of public infrastructure like roads, bridges, buildings is an important mandate for the government and a major yardstick of growth. Majority of this growth can be attributed to the

Pharma firms beware, CCI is inquiring!

The Competition Commission of India’s (CCI) order dated February 10 imposing, for the first time, a penalty of R74.63 crore on a major pharmaceutical company (at a rate of only